Literature DB >> 27637383

Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect.

Peter D Sly1, Julie Varghese2, Farhana Noor2, Mimi L K Tang3, Ingrid Laing4, Steve Oo5, Franciska Prastanti4, Peter N LeSouef6, Patrick G Holt7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27637383     DOI： 10.1016/j.jaci.2016.07.035

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  2 in total

Review 1.  Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthma.

Authors:  Daniel P Henriksen; Uffe Bodtger; Kirsten Sidenius; Niels Maltbaek; Lars Pedersen; Hanne Madsen; Ehm A Andersson; Ole Norgaard; Louise K Madsen; Bo L Chawes
Journal:  Allergy Asthma Clin Immunol       Date:  2020-06-18       Impact factor: 3.406

2.  Efficacy and Safety of Omalizumab for the Treatment of Severe or Poorly Controlled Allergic Diseases in Children: A Systematic Review and Meta-Analysis.

Authors:  Ling Liu; Pengxiang Zhou; Zhenhuan Wang; Suodi Zhai; Wei Zhou
Journal:  Front Pediatr       Date:  2022-03-15       Impact factor: 3.418
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.